Unlock instant, AI-driven research and patent intelligence for your innovation.

Indole derivative and medical application thereof

A kind of indole and pharmaceutical technology, applied in the field of biomedicine, can solve problems such as cardiotoxicity

Inactive Publication Date: 2020-12-04
CHINA PHARM UNIV +1
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, it has been reported that inhibition of FABP3 may cause cardiotoxicity (FASEB J.1999,13,805)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Indole derivative and medical application thereof
  • Indole derivative and medical application thereof
  • Indole derivative and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0122] 6-Chloro-3-(diethylamino)-5-fluoro-1-phenyl-1H-indole-2-carboxylic acid (Compound 1)

[0123]

[0124]

[0125] Get compound I-1 (20g, 137mmol) and place in round-bottomed flask (1L), add water (411mL) and concentrated hydrochloric acid (137mL), under ice bath slowly add dropwise the aqueous solution of sodium nitrite (10.4g, 151mmol) ( 82mL), after adding, continue stirring under ice bath for 45 minutes, add the concentrated hydrochloric acid solution (68.5mL) of stannous chloride dihydrate (61.8g, 274mmol) in the reaction solution, a large amount of solids are separated out, add, slowly Rising to room temperature, the reaction solution was suction-filtered, the filter cake was washed successively with saturated brine (50mL×2) and diethyl ether (50mL×2), and dried in vacuo to obtain compound I-2 (red-brown solid, 24.2g, yield 90% ): 1 H NMR (300MHz, DMSO-d 6 )δ10.53(s,3H),8.57(s,1H),7.43-7.21(m,2H),7.14-6.96(m,1H).

[0126] Compound I-2 (24.2g, 123mmol) was su...

Embodiment 2

[0133] 4-Chloro-3-(diethylamino)-5-fluoro-1-phenyl-1H-indole-2-carboxylic acid (compound 2)

[0134]

[0135] Suspend compound I-9 (715mg, 2.15mmol) and potassium carbonate (594mg, 4.30mmol) in acetonitrile (1mL), add iodoethane (1.02mL, 17.18mmol) to the reaction solution, seal the tube and heat and stir at 100°C 24 hours. After the reaction of the raw materials was completed, the heating was stopped, cooled to room temperature, the solvent was evaporated under reduced pressure, and the residue was purified by column chromatography (petroleum ether: ethyl acetate = 100:1) to obtain compound II-1 (yellow oily liquid, 760mg , yield 91%): 1 H NMR (300MHz, CDCl 3 )δ7.52-7.39(m,3H),7.33-7.28(m,2H),7.17(dd,J=8.8,6.8Hz,1H),6.86(d,J=8.8Hz,1H),4.13(q ,J=7.1Hz,2H),3.23-3.14(m,4H),1.09-0.99(m,9H).

[0136] Compound II-1 (100mg, 2.95mmol) was dissolved in a mixed solution of methanol and tetrahydrofuran (4.5mL, v:v=1:2), and aqueous potassium hydroxide solution (1.5mL, 1.5mmol) wa...

Embodiment 3

[0138] 3-(Diethylamino)-5-fluoro-1-phenyl-1H-indole-2-carboxylic acid (Compound 3)

[0139]

[0140] Compound 3 was obtained by referring to the method of Example 1: 1 H NMR (300MHz, DMSO-d 6 )δ16.12(s,1H),7.88-7.80(m,1H),7.60-7.47(m,3H),7.44-7.36(m,2H),7.27-7.17(m,1H),7.14-7.06( m, 1H), 3.44(q, J=7.2Hz, 4H), 1.04(t, J=7.2Hz, 6H).ESI-MS: m / z 349.1[M+Na] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an indole compound with FABP4 / 5 inhibitory activity and a preparation method and medical application of the indole compound. The indole compound is a compound of which the structural formula is shown as a formula I, and pharmaceutically acceptable salt or ester or solvate of the compound. The compound shown in the formula I is a novel FABP4 / 5 inhibitor and can be used for preparing medicines for preventing or treating FABP4 / 5 related diseases.

Description

technical field [0001] The present invention relates to the field of biomedicine, in particular to inhibitors of fatty acid binding protein (FABP) 4 and / or 5, more specifically to indole novel FABP4 / 5 inhibitors, and the present invention also relates to a preparation method of such compounds and their use as Medicinal uses of FABP4 / 5 inhibitors. Background technique [0002] Fatty acid binding proteins (FABPs), as intracellular lipid chaperones, can reversibly bind to lipids, increase their solubility in the cytoplasm, and reduce lipotoxicity. There are many subtypes in the FABP family, among which FABP4 (adipocyte-FABP, A-FABP) and FABP5 (epidermal-FABP, E-FABP) are members of the fatty acid binding protein family. FABP4 is mainly distributed in adipocytes and macrophages, accounting for 1% of the total protein in adipose tissue. FABP5 is distributed in a wide range of tissues. FABP4 / 5 is closely related to the occurrence and development of metabolic inflammatory diseas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/42C07D405/04C07D403/04C07D209/40C07D405/12A61K31/404A61K31/454A61K31/55A61K31/5377A61K31/496A61K31/41A61K31/541A61P3/00A61P9/00A61P29/00A61P37/00A61P25/00A61P35/02A61P35/00
CPCC07D209/42C07D405/04C07D403/04C07D209/40C07D405/12A61P3/00A61P9/00A61P29/00A61P37/00A61P25/00A61P35/02A61P35/00A61K31/41A61K31/404A61K31/454A61K31/496A61K31/5377A61K31/541A61K31/55
Inventor 孙宏斌王贺瑶王朝鑫袁浩亮韩立帅吴文珍豆会霞陈梦婷杨春伟
Owner CHINA PHARM UNIV